NCT03844750 2025-12-31
Preoperative Immunotherapy (Pembrolizumab) for Patients With Colorectal Cancer and Resectable Hepatic Metastases
University of California, San Francisco
Phase 2 Terminated
Clinical Trials
10 trialsNCT04840186 2024-11-12
EXCALIBUR3
Oslo University Hospital
Phase 2 Suspended
NCT06329700 2024-03-26
Parenchymal Sparing Hepatectomy in Post-chemotherapy Liver Atrophy
Azienda Ospedaliero Universitaria Maggiore della Carita
Completed
NCT01479608 2024-02-07
Liver Transplantation and Colorectal Cancer
Oslo University Hospital
Phase NA Recruiting
NCT04513457 2021-03-29
Chemotherapy for Resectable Colorectal Liver Metastases
Fundación de Investigación Biomédica - Hospital Universitario de La Princesa
Completed
NCT02954913 2021-02-12
RESECT
Hamilton Health Sciences Corporation
Phase NA Completed
NCT03888638 2019-03-25
The Role of Tumor-associated Macrophages in Colorectal Liver Metastases
Humanitas Clinical and Research Center
Completed
NCT03551470 2018-06-11
Minimally Invasive Simultaneous Colorectal and Liver Surgery
Azienda Ospedaliera San Giovanni Battista
Unknown
NCT03131778 2017-05-01
The Inflammatory Response to Stress and Angiogenesis in Liver Resection
University Hospital, Ghent
Phase NA Completed
NCT00153998 2009-02-27
Cetuximab in Neoadjuvant Treatment of Non-Resectable Colorectal Liver Metastases (CELIM)
Technische Universität Dresden
Phase 2 Completed